started · updated
Poland replaces traditional cytology with HPV HR testing in NFZ program
As of August 1, 2026, the National Health Fund (NFZ) has replaced traditional cytology with the HPV HR molecular test as the primary method in its cervical cancer prevention program. This change follows a regulation issued by the Minister of Health on June 3, 2026.
Unlike traditional cytology, which examines cells under a microscope for abnormalities, the new HPV HR test identifies the genetic material of high-risk human papillomavirus types, specifically focusing on types 16 and 18. This method allows for the detection of infection before cellular changes occur, enabling earlier risk assessment.
The screening program is available free of charge to women aged 25 to 64. While the sample collection process remains similar to traditional cytology, the diagnostic workflow has changed: if an HPV HR test returns a positive result, a liquid cytology is performed on the same sample to evaluate the cells, eliminating the need for a separate collection visit.